Barclays’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.29M Sell
35,371
-40,611
-53% -$3.6M ﹤0.01% 2067
2025
Q4
$6.1M Buy
75,982
+6,397
+9% +$536K ﹤0.01% 2055
2025
Q3
$6.79M Sell
69,585
-8,702
-11% -$701K ﹤0.01% 1977
2025
Q2
$5.46M Buy
78,287
+21,977
+39% +$1.25M ﹤0.01% 2047
2025
Q1
$2.8M Sell
56,310
-17,161
-23% -$1.09M ﹤0.01% 2375
2024
Q4
$5.13M Buy
73,471
+5,360
+8% +$445K ﹤0.01% 2143
2024
Q3
$7.14M Sell
68,111
-93,416
-58% -$10.9M ﹤0.01% 1748
2024
Q2
$23M Sell
161,527
-30,949
-16% -$3.57M 0.01% 887
2024
Q1
$21.5M Buy
192,476
+5,276
+3% +$629K 0.01% 948
2023
Q4
$24.3M Buy
187,200
+86,791
+86% +$12M 0.01% 971
2023
Q3
$16.4M Buy
100,409
+73,053
+267% +$12.8M 0.01% 818
2023
Q2
$5.02M Sell
27,356
-8,554
-24% -$1.23M ﹤0.01% 1344
2023
Q1
$4.79M Buy
35,910
+1,659
+5% +$195K ﹤0.01% 1573
2022
Q4
$2.72M Sell
34,251
-238
-0.7% -$16.8K ﹤0.01% 2035
2022
Q3
$2.09M Sell
34,489
-5,195
-13% -$336K ﹤0.01% 1716
2022
Q2
$2.18M Sell
39,684
-8,945
-18% -$518K ﹤0.01% 1806
2022
Q1
$3.67M Sell
48,629
-8,212
-14% -$561K ﹤0.01% 1419
2021
Q4
$4.24M Buy
56,841
+15,510
+38% +$919K ﹤0.01% 1830
2021
Q3
$1.94M Buy
41,331
+10,089
+32% +$439K ﹤0.01% 2384
2021
Q2
$1.26M Sell
31,242
-19,046
-38% -$789K ﹤0.01% 2510
2021
Q1
$2.07M Buy
50,288
+6,536
+15% +$244K ﹤0.01% 2242
2020
Q4
$1.27M Buy
43,752
+814
+2% +$21.1K ﹤0.01% 2588
2020
Q3
$946K Sell
42,938
-12,079
-22% -$308K ﹤0.01% 2741
2020
Q2
$1.53M Buy
55,017
+758
+1% +$18.5K ﹤0.01% 2368
2020
Q1
$993K Buy
54,259
+5,239
+11% +$122K ﹤0.01% 2962
2019
Q4
$1.18M Buy
49,020
+5,457
+13% +$115K ﹤0.01% 3531
2019
Q3
$746K Sell
43,563
-7,720
-15% -$123K ﹤0.01% 3918
2019
Q2
$772K Buy
51,283
+14,718
+40% +$263K ﹤0.01% 3949
2019
Q1
$735K Buy
36,565
+3,086
+9% +$62.7K ﹤0.01% 3739
2018
Q4
$596K Sell
33,479
-16,145
-33% -$287K ﹤0.01% 3644
2018
Q3
$976K Buy
49,624
+31,038
+167% +$639K ﹤0.01% 3649
2018
Q2
$368K Sell
18,586
-6,072
-25% -$133K ﹤0.01% 4214
2018
Q1
$607K Buy
24,658
+6,780
+38% +$178K ﹤0.01% 3760
2017
Q4
$513K Buy
17,878
+14,210
+387% +$447K ﹤0.01% 3803
2017
Q3
$100K Sell
3,668
-18,246
-83% -$404K ﹤0.01% 4938
2017
Q2
$459K Buy
21,914
+11,330
+107% +$239K ﹤0.01% 3611
2017
Q1
$199K Buy
+10,584
New +$167K ﹤0.01% 4327
2016
Q4
Sell
-4,978
Closed -$66K 6573
2016
Q3
$66K Sell
4,978
-522
-9% -$6.06K ﹤0.01% 4808
2016
Q2
$59K Buy
5,500
+220
+4% +$2.36K ﹤0.01% 4743
2016
Q1
$42K Buy
+5,280
New +$54K ﹤0.01% 4867
2015
Q4
Sell
-291
Closed -$2K 5946
2015
Q3
$2K Sell
291
-252
-46% -$3.07K ﹤0.01% 6293
2015
Q2
$4K Sell
543
-296
-35% -$3.43K ﹤0.01% 6534
2015
Q1
$7K Sell
839
-3,670
-81% -$37.9K ﹤0.01% 6394
2014
Q4
$36K Buy
4,509
+3,527
+359% +$30.6K ﹤0.01% 5948
2014
Q3
$4K Sell
982
-1,399
-59% -$10.5K ﹤0.01% 7225
2014
Q2
$19K Sell
2,381
-10,452
-81% -$77.9K ﹤0.01% 6524
2014
Q1
$103K Sell
12,833
-17,422
-58% -$160K ﹤0.01% 5428
2013
Q4
$242K Buy
30,255
+2,539
+9% +$23K ﹤0.01% 4828
2013
Q3
$221K Buy
27,716
+15,945
+135% +$129K ﹤0.01% 4943
2013
Q2
$86K Buy
+11,771
New +$68.4K ﹤0.01% 5898

Other funds holding ACLS

Barclays's ACLS Position: Q1 2026 in Review

Barclays reduced its Axcelis (ACLS) stake by 53% in Q1 2026, selling an estimated $3.6M and leaving 35,371 shares worth $3.29M. The position accounts for ﹤0.01% of the portfolio, ranked #2067.

Barclays first reported a position in ACLS in Q2 2013 and has held it in 50 quarters since. The position peaked at $24.3M in Q4 2023. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Barclays held 35,371 shares of Axcelis worth $3.29M as of Q1 2026.
  • Barclays sold 40,611 Axcelis shares in Q1 2026, an estimated $3.6M.
  • Axcelis made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2067 holding.
  • Barclays first reported a position in Axcelis in Q2 2013 and has held it in 50 quarters since.
  • Barclays's Axcelis position peaked at $24.3M in Q4 2023.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.